Health Care Reform: 2 Views

Health Care Reform: 2 Views STRIKING THE RIGHT BALANCE © Greg Betza We need to improve our healthcare system and allow the life science industries to flourish. By Sean Harper On healthcare reform it’s hard to find consensus. The one point everyone is in agreement on is that the current system is broken, and something must be done to fix it. The Obama administration and Congress are eager to enact

| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

We need to improve our healthcare system and allow the life science industries to flourish.

By Sean Harper

On healthcare reform it’s hard to find consensus. The one point everyone is in agreement on is that the current system is broken, and something must be done to fix it. The Obama administration and Congress are eager to enact broad reforms to improve care and access, and quickly. This is a commendable aim, one that Amgen fully supports. But in the rush to make change happen, it’s important to consider the long-term consequences of decisions made today.

Reforming the healthcare system can’t begin and end with cutting costs. Striking and maintaining the right balance between reform and preserving medical innovation and patient access will be challenging. Throughout the process, there are a few basic truths that should be kept in mind.

Bailed out by science

Manufacturing on a Grand Scale

The ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Sean Harper

    This person does not yet have a bio.
  • Dennis J. Cotter

    This person does not yet have a bio.
  • Mae Thamer

    This person does not yet have a bio.
  • Yi Zhang

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo